Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration

被引:55
作者
Lin, H. [1 ]
Lin, T-Y [1 ]
Juang, J-L [1 ]
机构
[1] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 350, Miaoli, Taiwan
关键词
Abl; Cdk5; Drosophila; Alzheimer's disease; neurodegeneration;
D O I
10.1038/sj.cdd.4402033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although Abl functions in mature neurons, work to date has not addressed Abl's role on Cdk5 in neurodegeneration. We found that beta-amyloid (A beta 42) initiated Abl kinase activity and that blockade of Abl kinase rescued both Drosophila and mammalian neuronal cells from cell death. We also found activated Abl kinase to be necessary for the binding, activation, and translocalization of Cdk5 in Drosophila neuronal cells. Conversion of p35 into p25 was not observed in A beta 42-triggered Drosophila neurodegeneration, suggesting that Cdk5 activation and protein translocalization can be p25-independent. Our genetic studies also showed that abl mutations repressed A beta 42-induced Cdk5 activity and neurodegeneration in Drosophila eyes. Although A beta 42 induced conversion of p35 to p25 in mammalian cells, it did not sufficiently induce Cdk5 activation when c-Abl kinase activity was suppressed. Therefore, we propose that Abl and p35/p25 cooperate in promoting Cdk5-pY15, which deregulates Cdk5 activity and subcellular localization in Ab42-triggered neurodegeneration.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 41 条
[1]   A cdk5-p35 stable complex is involved in the β-amyloid-induced deregulation of cdk5 activity in hippocampal neurons [J].
Alvarez, A ;
Muñoz, JP ;
Maccioni, RB .
EXPERIMENTAL CELL RESEARCH, 2001, 264 (02) :266-274
[2]   Drosophila models of human neurodegenerative disease [J].
Chan, HYE ;
Bonini, NM .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (11) :1075-1080
[3]   The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo [J].
Connell-Crowley, L ;
Le Gall, M ;
Vo, DJ ;
Giniger, E .
CURRENT BIOLOGY, 2000, 10 (10) :599-602
[4]   Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease [J].
Crowther, DC ;
Kinghorn, KJ ;
Miranda, E ;
Page, R ;
Curry, JA ;
Duthie, FAI ;
Gubb, DC ;
Lomas, DA .
NEUROSCIENCE, 2005, 132 (01) :123-135
[5]   The development of imatinib as a therapeutic agent for chronic myeloid leukemia [J].
Deininger, M ;
Buchdunger, E ;
Druker, BJ .
BLOOD, 2005, 105 (07) :2640-2653
[6]   DYNAMICS OF EXCITON TRANSFER BETWEEN MONOLAYER-FLAT ISLANDS IN SINGLE QUANTUM-WELLS [J].
DEVEAUD, B ;
DAMEN, TC ;
SHAH, J ;
TU, CW .
APPLIED PHYSICS LETTERS, 1987, 51 (11) :828-830
[7]   A decade of CDK5 [J].
Dhavan, R ;
Tsai, LH .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :749-759
[8]   A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster [J].
Finelli, A ;
Kelkar, A ;
Song, HJ ;
Yang, HD ;
Konsolaki, M .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 26 (03) :365-375
[9]   Immunotherapy for Alzheimer's disease [J].
Gelinas, DS ;
DaSilva, K ;
Fenili, D ;
George-Hyslop, PS ;
McLaurin, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 :14657-14662
[10]   ENABLED, A DOSAGE-SENSITIVE SUPPRESSOR OF MUTATIONS IN THE DROSOPHILA ABL TYROSINE KINASE, ENCODES AN ABL SUBSTRATE WITH SH3 DOMAIN-BINDING PROPERTIES [J].
GERTLER, FB ;
COMER, AR ;
JUANG, JL ;
AHERN, SM ;
CLARK, MJ ;
LIEBL, EC ;
HOFFMANN, FM .
GENES & DEVELOPMENT, 1995, 9 (05) :521-533